Quinolones are important antimicrobials for treatment of leprosy, a chronic infectious 16 disease caused by Mycobacterium leprae. Although it is well known that mutations in DNA gyrase are 17 responsible for quinolone resistance, the effect of those mutations on the enzymatic activity is yet to 18 be studied in depth. Hence, we conducted in vitro assays to observe supercoiling reactions of wild 19 type and mutated M. leprae DNA gyrases. DNA gyrase with amino acid substitution Ala91Val 20 possessed the highest activity among the mutants. DNA gyrase with Gly89Cys showed the lowest 21 level of activity despite being found in clinical strains, but supercoiled DNA like the wild type does if 22 applied at a sufficient concentration. DNA gyrases with clinically unreported Asp95Gly and 23 Asp95Asn supercoiled DNA in a different manner than the other DNA gyrases did. We speculate that 24 this alteration may represent a reason this substitution is not found in clinical strains. 25 3 Keywords 26 DNA gyrase, Mycobacterium leprae, quinolone resistance, amino acid substitution, enzymatic activity 27 28
Introduction 29
Mycobacterium leprae is an unculturable bacterium that causes leprosy, also known as 30
Hansen's disease. Although this chronic infectious disease had been considered to be incurable for a 31 long time, it is now well accepted that this disease can be treated by chemotherapy 1 . Owing to a 32 multidrug therapy introduced by the World Health Organization in the 1980s, world prevalence of 33 leprosy has been dramatically reduced. Nonetheless, more than 210,000 new cases still occur every 34
year mainly in Asian, Latin American, and African countries 2,3 . 35
Quinolones, including fluoroquinolone, are recognized as an important antimicrobial class 36 widely used for treatment of various bacterial infections including leprosy 4 . For example, quinolones 37 are regularly used for treatment of single-skin lesion paucibacillary leprosy. Quinolones are also 38 reportedly effective against multibacillary leprosy 5,6 . This antimicrobial class inhibits the activity of 39 DNA gyrase, which is an essential enzyme for bacteria. DNA gyrase contributes to DNA transcription 40 and replication by introducing negative supercoils into circular DNA to alleviate positive supercoils 41 accumulated during those processes 7 . As quinolones interfere with DNA gyrase supercoiling activity 42 by binding to the site where DNA gyrase cleaves double stranded DNA, amino acid substitutions at 43 this quinolone-binding site can cause resistance to quinolones 8 . 44 In clinical strains of M. leprae, two types of amino acid substitution in DNA gyrase subunits A 45 (GyrA), glycine at position 89 to cysteine (Gly89Cys) and alanine at position 91 to valine (Ala91Val), 46 have been found to be responsible for acquisition of quinolone resistance. However, it has been 47 reported that the majority of quinolone-resistant M. leprae strains has Ala91Val substitution, and that 48 Gly89Cys substitution can be found only in a very limited number of cases 9-11 . In addition to these 49 amino acid substitutions found at clinical level, we previously demonstrated that 50 experimentally-induced substitutions of aspartic acid at position 95 to glycine (Asp95Gly) and 51 aspartic acid at position 95 to asparagine (Asp95Asn) also hinder the inhibitory activity of quinolones 52 12 . Moreover, although Asp95Gly and Asp95Asn have not been found in clinical M. leprae strains, 53 their equivalent substitutions, aspartic acid at position 94 to glycine (Asp94Gly) and to asparagine 54 5 (Asp94Asn), are frequently reported in M. tuberculosis isolates 13-15 . 55
As mentioned above, it is already clarified and proven that all four types of amino acid 56 substitutions contribute to quinolone resistance. Nevertheless, the effect of these amino acid 57 substitutions on M. leprae DNA gyrase activity itself, and the reason Asp95Gly has been unreported 58 until now remain unclear. Hence, to further elucidate the enzymatic activity of wild type (WT) and 59 mutant M. leprae DNA gyrases with Gly89Cys, Ala91Val, Asp95Gly and Asn95Asn, we conducted in 60 vitro assays using recombinant DNA gyrase subunits. GyrA with Asp95Asn (Asp95Asn-GyrA) and WT DNA gyrase subunit B (GyrB) were constructed as 76 described in our previous studies 12, 17 . 77
Recombinant DNA gyrase subunits were expressed and purified as previously described 78 12, [17] [18] [19] . The purified proteins were examined by sodium dodecyl sulfate-polyacrylamide gel 79 electrophoresis (SDS-PAGE) with Prestained Protein Marker, Broad Range (7-175 kDa) (New 80 England Biolab; Hitchin, UK). 81 82 Time course DNA supercoiling assay 83 Time course DNA supercoiling assays were carried out under the following conditions. 84
Each assay was carried out in 30 µL of DNA gyrase reaction buffer (35 mM Tris-HCl pH 7.5, 6 mM 85 MgCl2, 1.8 mM spermidine, 24 mM KCl, 5 mM DTT, 0.36 mg/mL of BSA, 6.5% w/v glycerol, 1mM 86 7 ATP), with 2 nM relaxed pBR322 DNA, 8 nM GyrA (WT GyrA, Gly89Cys-GyrA, Ala91Val-GyrA, 87
Asp95Gly-GyrA or Asn95Asn-GyrA) and 8 nM WT GyrB. The reactions were continued at 30 °C and 88 stopped at 0, 10, 20, 40, 60, 90, 120, 240, 360 and 600 min by addition of 7.5 µL of 5× dye mix (5% 89 SDS, 25% glycerol, 0.25 mg/mL of bromophenol blue). Next, 10 µL of each mixture was subjected to 90 electrophoresis with Lambda DNA-HindIII Digest (New England Biolabs) on 1% agarose 1× TBE 91 gels and stained with 1 µg/mL of ethidium bromide. To assess the activity of DNA gyrases, the 92 amount of DNA supercoiled in the reactions was quantified with ImageJ (http://rsbweb.nih.gov/ij/) by 93 comparing band brightness of the supercoiled DNA with that of the Lambda DNA-HindIII Digest. 94
Each assay was conducted thrice to confirm its reproducibility. supercoiling assay. Each GyrA (WT, Gly89Cys-, Ala91Val-, Asp95Gly-or Asp95Asn-GyrA) was 109 mixed with WT GyrB to form DNA gyrase and its supercoiling activity was observed for 600 min. 110
Obtained electrophoretic images showed sequential changes of supercoiling by WT and mutant DNA 111 gyrases ( Fig. 1A) . Then, reaction curves of DNA gyrases were obtained by analyzing the intensity of 112 each band on the images at the position of the supercoiled form ( Fig. 1B) . WT DNA gyrase yielded 113 the highest amount of supercoiled DNA. In comparison, the amounts of supercoiled DNA produced 114 by DNA gyrases with Gly89Cys-, Ala91Val-, Asp95Gly-and Asp95Asn-GyrA at 600 minutes were 115 22.0%, 68.9%, 30.7% and 69.1%, respectively, of the amount produced by the WT (Table 1) . 116 Furthermore, in the assays using DNA gyrases with Asp95Gly-and Asp95Asn-GyrA, some part of the 117 input relaxed DNA remained unsupercoiled at its initial position after the 10-hour reaction ( Fig. 1A  118 and 1C). supercoiling assays to examine the supercoiling activity of WT and three mutant types of DNA 137 gyrases. Our results clearly showed a particular effect of each amino acid substitution on the 138 supercoiling activity of DNA gyrase (Fig. 1) . Using time course assays, we showed that amino acid 139 substitution Ala91Val causes the least effect on the supercoiling activity of M. leprae DNA gyrase. 140
Even though our previous studies established that the level of quinolone-resistance conferred by this 141 substitution was the lowest 12,17 , considering the highest supercoiling activity among the tested mutant 142 DNA gyrases, it seems reasonable that this amino acid substitution is selected by the majority of 143 quinolone-resistant M. leprae strains. 144
Unlike DNA gyrase with Ala91Val amino acid substitution found at clinical level, DNA 145 gyrase with Gly89Cys-GyrA showed the lowest supercoiling activity. Nonetheless, the fact that this 146 amino acid substitution was found in clinical M. leprae strains is a strong evidence that DNA gyrase 147 with Gly89Cys-GyrA does not totally lose enzymatic activity 9,10 . The electrophoretic image and its 148 band intensities indicated that DNA gyrase with Gly89Cys-GyrA was gradually converting the entire 149 set of input relaxed DNA molecules to the supercoiled form in a similar manner as DNA gyrases with 150 WT and Ala91Val-GyrA did, even though the supercoiling was quite slow (Fig. 1 ). Therefore, it seems 151 that the amount of DNA gyrase is important for the rate by which DNA gyrase with Gly89Cys-GyrA 152 supercoils. To demonstrate that the DNA supercoiling rate can be supplemented by the molecular 153 amount of DNA gyrase subunits, we conducted an additional assay of time course DNA supercoiling 154 by changing the molecular ratio of circular DNA and DNA gyrase from 1:1 to 1:3 (from 1:2:2 to 1:6:6 155 as the ratio of circular DNA, GyrA and GyrB). In this assay, to clearly identify the difference between 156 assay conditions, the amount of relaxed DNA was applied twice (4 nM) to assist the low supercoiling 157 activity of DNA gyrase with Gly89Cys-GyrA. The results obtained from this assay clearly showed 158 that the amount of supercoiled DNA produced by DNA gyrase with Gly89Cys-GyrA can be increased 159 11 when larger amounts of DNA gyrase subunits are added. In addition, both the electrophoretic images 160 and the reaction curves showed that the supercoiling activity of DNA gyrase with Gly89Cys became 161 more similar to that of WT, as a larger amount of enzymes was introduced (Fig. 2) . These findings 162 suggested that DNA gyrase with Gly89Cys can act similarly to that of WT as long as subunits are 163 sufficiently expressed in the bacterial cells. However, it should be noted that the time course assays in 164 this study had a limitation since they were not conducted with the same DNA and DNA gyrase 165 concentrations as those found in actual bacterial cells. Therefore, to estimate and discuss the in vivo tuberculosis. We previously conducted in vitro assays using recombinant DNA gyrases with 172
Asp95Gly and Asp95Asn, and demonstrated that these substitutions can also contribute to quinolone 173 resistance 12, 17 . It had been shown that the levels of quinolone resistance brought about by Asp95Gly 174 and Asn95Asn are higher than that by Ala91Val, and the higher than that by Gly89Cys (Table 1 ). In 175 this study, we revealed that those amino acid substitutions at position 95, especially Asp95Gly, largely 176 decreased the supercoiling activity of M. leprae DNA gyrase. However, the supercoiling activities of 177 M. leprae DNA gyrases with those amino acid substitutions were still higher than that by DNA gyrase 178 with Gly89Cys-GyrA, which has been reported in clinical strains 9 . The supercoiling process between 179 DNA gyrase with Asp95Gly-or Asp95Asn-GyrA and the other tested DNA gyrases was clearly 180 different in the electrophoresis images (Fig. 1A) . As DNA gyrase with Asp95Gly-or Asp95Asn-GyrA 181 did not supercoil all the input relaxed DNA molecules, part of the relaxed DNA seemed to remain at 182 its initial positions, whereas DNA gyrases found at clinical level, including WT, gradually supercoiled 183 the entire set of input relaxed DNA molecules ( Fig. 1A and 1C ). It seems that the change in the 184 supercoiling process reflected a defect in the function of M. leprae DNA gyrase caused by Asp95Gly 12 or Asp95Asn, which may be one of reasons for no previous report of Asp95Gly and Asp95Asn at 186 clinical level, despite conferring high levels of quinolone resistance while keeping the supercoiling 187 activity higher than Gly89Cys (Table 1 ). We speculate that DNA gyrase with Asp95Gly or Asp95Asn 188 less frequently move out from the bound DNA molecule to another after giving a supercoil than the 189 other DNA gyrases, and that the excessive persistence might be adverse to the function of DNA 190 gyrase as an enzyme supporting DNA replication and transcription. Therefore, it was considered that 191 quinolone resistance-conferring mutations in DNA gyrase are selected by multiplex factors, not only 192 by the supercoiling activity or the level of quinolone resistance. To confirm these speculations, we 193 plan further analysis to examine other DNA gyrase properties, including DNA-DNA gyrase binding 194 affinity. In addition, more data of quinolone-resistant M. leprae strains should be accumulated since 195 clinical reports of those strains are still too scarce to discuss and determine the possibility of 196
Asp95Gly and Asp95Asn to occur in M. leprae. 197 In summary, we showed that amino acid substitutions that confer quinolone resistance to M. 
